Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | RGLS | PYXS | ||
| Company | Champions Oncolog | Regulus Therapeutics | Pyxis Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.64 | 1.5300 | 1.5400 | ||
| High | 7.66 | 1.6000 | 1.6950 | ||
| Low | 7.15 | 1.5101 | 1.5100 | ||
| Last | 7.51 | 1.5900 | 1.6900 | ||
| Change | -0.05 | +0.0400 | +0.1500 | ||
| % Change | -0.60% | +2.58% | +9.74% | ||
| Volume | 119,100 | 462,200 | 1,778,800 | ||
| 20-Day Average Volume | 61,800 | 275,070 | 1,663,395 | ||
| Previous Close | 7.55 | 1.5500 | 1.5400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.29 | 1.5875 | 1.7365 | ||
| 20-Day Raw Stochastic | 90.88% | 55.00% | 31.25% | ||
| 20-Day Relative Strength | 73.96% | 51.61% | 35.23% | ||
| Weighted Alpha | +44.88 | +0.77 | -14.93 | ||
| Today's Opinion | 56% Buy | 8% Sell | 100% Sell | ||
| Previous Opinion | 56% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 80% Sell | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.56% since 12/13/24 | +0.63% since 12/13/24 | +4.32% since 12/13/24 | ||
| Low | 6.06 on 12/16/24 | 1.5000 on 12/19/24 | 1.4900 on 12/19/24 | ||
| High | 7.85 on 12/19/24 | 1.7000 on 12/16/24 | 1.7100 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +73.73% since 11/20/24 | +13.57% since 11/20/24 | -55.76% since 11/20/24 | ||
| Low | 4.07 on 11/29/24 | 1.3000 on 11/21/24 | 1.4900 on 12/19/24 | ||
| High | 7.85 on 12/19/24 | 1.7700 on 12/11/24 | 2.3900 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | +57.34% since 09/20/24 | -12.64% since 09/20/24 | -54.20% since 09/20/24 | ||
| Low | 3.75 on 10/31/24 | 1.3000 on 11/21/24 | 1.4900 on 12/19/24 | ||
| High | 7.85 on 12/19/24 | 1.8480 on 09/23/24 | 5.3899 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +55.38% since 06/20/24 | -36.90% since 06/20/24 | -50.00% since 06/20/24 | ||
| Low | 3.60 on 09/10/24 | 1.3000 on 11/21/24 | 1.4900 on 12/19/24 | ||
| High | 7.85 on 12/19/24 | 2.5900 on 06/21/24 | 5.3899 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 103,712 | 104,145 | 100,498 | ||
| Shares Outstanding, K | 13,819 | 65,500 | 59,466 | ||
| Annual Sales | 50,160,000 | 0 | 0 | ||
| Annual Net Income | -7,280,000 | -30,040,000 | -73,790,000 | ||
| Last Quarter Sales | 13,490,000 | 0 | 0 | ||
| Last Quarter Net Income | 730,000 | -14,060,000 | -17,300,000 | ||
| 60-Month Beta | 0.52 | 1.61 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 12/11/24 | -0.21 on 11/07/24 | -0.35 on 11/12/24 | ||
| Latest Earnings Date | 12/11/24 | 11/14/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||